Premium
Stage IB 2 adenosquamous cervical cancer diagnosed at 19‐weeks' gestation
Author(s) -
Peculis Luiza D.,
Ius Yvette,
Campion Michael,
Friedlander Michael,
Hacker Neville
Publication year - 2015
Publication title -
australian and new zealand journal of obstetrics and gynaecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.734
H-Index - 65
eISSN - 1479-828X
pISSN - 0004-8666
DOI - 10.1111/ajo.12281
Subject(s) - medicine , adenosquamous carcinoma , cervical cancer , stage (stratigraphy) , gestation , cervix , histopathology , caesarean section , radical hysterectomy , hysterectomy , pregnancy , chemotherapy , cancer , surgery , adenocarcinoma , gynecology , pathology , paleontology , genetics , biology
Neoadjuvant chemotherapy ( NACT ) for advanced cervical cancer in pregnancy has been shown to increase operability and be effective against spread of disease. In all reported cases of advanced disease, residual tumour has been found at surgery following NACT . We present a case of a 27‐year old diagnosed with stage IB 2 adenosquamous cervical carcinoma at 19‐weeks' gestation who was treated with NACT . Following caesarean section and radical hysterectomy, histopathology showed no evidence of residual tumour in the cervix and negative pelvic lymph nodes.